IP 13 (Alprazolam extended-release 3 mg)
Pill imprint IP 13 has been identified as Alprazolam extended-release 3 mg.
Alprazolam is used in the treatment of anxiety; panic disorder; depression; tinnitus; dysautonomia and belongs to the drug class benzodiazepines. There is positive evidence of human fetal risk during pregnancy. Alprazolam 3 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
See also related documents.
Images for IP 13
- 3 mg
- Prescription only
- Drug Class:
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- 4 - Some potential for abuse
- Amneal Pharmaceuticals
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|21695-0605||Rebel Distributors Corp (repackager)|
Note: Inactive ingredients may vary.
More about alprazolam
- Alprazolam extended-release tablets
- Alprazolam orally disintegrating tablets
- Alprazolam solution
- Alprazolam (Advanced Reading)
- Alprazolam Oral (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.